• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CA 19-9 ELECSYS E2G; CARBOHYDRATE ANTIGEN (CA19-9) TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CA 19-9 ELECSYS E2G; CARBOHYDRATE ANTIGEN (CA19-9) TEST SYSTEM Back to Search Results
Model Number CA 19-9 ELECSYS E2G
Device Problem Non Reproducible Results (4029)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/10/2019
Event Type  malfunction  
Manufacturer Narrative
The investigation is ongoing.This event occurred in (b)(6).
 
Event Description
The initial reporter received questionable elecsys ca 19-9 immunoassay results for one patient sample from the cobas e 801 module.The initial result was 140 u/ml.The repeat results were <6 u/ml and 6 u/ml.Since the previous result for the patient a year ago was <6 u/ml, the customer reported <6 u/ml to the physician.The reagent lot number was 352496.The expiration date was requested but was not provided.
 
Manufacturer Narrative
The investigation determined that there was reagent contamination, which occurred during the filling process of the elecsys ca 19-9 reagent cassettes lot number 416245 for the cobas e 801 module only.The issue is related to contamination of the reagent with magnetic particles.A replacement lot is not currently available.Roche has provided two workaround options to customers.The first workaround is customers may discontinue running the elecsys ca 19-9 assay on the e801 and instead run the ca 19-9 assay on the cobas e 411 analyzer, cobas e 601 and 602 modules, or the modular analytics e 170 module.The second workaround is customers can continue to run the ca 19-9 assay on the e801 and repeat all results =37 u/ml within 2 hours.Customers are also instructed to use only the first 200 determinations of the 300 test cobas e pack.Instructions for implementing these workarounds were communicated to customers by customer notification.Medwatch fields d1, d2, d4, g1, g5, and h9 were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CA 19-9 ELECSYS E2G
Type of Device
CARBOHYDRATE ANTIGEN (CA19-9) TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key9519595
MDR Text Key219778708
Report Number1823260-2019-04517
Device Sequence Number1
Product Code NIG
Combination Product (y/n)N
PMA/PMN Number
K050231
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 02/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/26/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCA 19-9 ELECSYS E2G
Device Catalogue Number07027028190
Device Lot Number416245
Was Device Available for Evaluation? Yes
Date Manufacturer Received12/10/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction Number1823260-02/05/20-001-C
Patient Sequence Number1
-
-